Photo taken from Margaret Gatti-Mays/X
Jun 22, 2024, 12:23
Margaret Gatti-Mays: To avoid adjuvant chemotherapy in small HER2+ breast tumors
Margaret Gatti-Mays, Co-Director of the Division of Medical Oncology at the Ohio State University, shared on X:
“Growing data that may be able to avoid adjuvant chemotherapy in small (5mm or less) HER2+ breast tumors. Great collaboration with CancerLinQ, The James, Ohio State Medical Oncology lead by Dr Kai Johnson, Dr Wesolowski.”
Read further.
Source: Margaret Gatti-Mays/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14